Benefit of Elevation of HDL-cholesterol/Triglyceride Lowering on Cardiovascular Outcomes in Women

Trial Profile

Benefit of Elevation of HDL-cholesterol/Triglyceride Lowering on Cardiovascular Outcomes in Women

Completed
Phase of Trial: Phase IV

Latest Information Update: 31 Mar 2017

At a glance

  • Drugs Niacin (Primary)
  • Indications Hyperlipidaemia
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 15 Aug 2013 New source identified an integrated: ClincialTrials.gov record NCT01921010.
    • 15 Aug 2013 New source identified an integrated: ClincialTrials.gov record NCT01921010.
    • 04 Apr 2011 Endpoint 'Endothelial-function' has not been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top